Fortress will receive ~$28 million shortly after closing and is eligible for an additional contingent value right (CVR) of up ...

SEATTLE, May 28, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will ...

Renewed interest in Life Sciences and Commerce streams in Bengaluru colleges, with fee hikes in government and private ...

Fungi pose a significant threat to cultural heritage, causing deterioration of historical artifacts, manuscripts, paintings, and architectural structures.

In a world shaped by biotechnology, why are so few college students exposed to its possibilities early on in their education?

Despite advancements in microbial safety strategies, agri-food systems remain vulnerable to microbial infections, posing significant threats to food safety, ...

Bharat Biotech International Ltd on Wednesday said its oral Cholera Vaccine Hillchol has successfully completed phase III ...

Fortress Biotech, Inc. (Nasdaq: FBIO) ("Fortress"), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value ...

The proposed sale is expected to close in the third quarter, subject to approval by the U.S. Bankruptcy Court for the Eastern ...

US-based pharmaceutical company Moleculin Biotech has begun dosing subjects in its Phase III MIRACLE trial of Annamycin with cytarabine for treating acute myeloid leukaemia (AML). The trial has ...